Author: Matthew Nelson|| Date Published: August 19, 2020
Ology Bioservices has won a one-year, $106.3M reserve production capacity contract for more than 186M doses of COVID-19 vaccines and other treatments to support the Trump administration's Operation Warp Speed.
Army Contracting Command received eight bids for the firm-fixed-price contract that seeks to address an urgent domestic requirement for aseptic fill and finish services amid the coronavirus pandemic, the Department of Defense said Tuesday.
The Alachua, Fla.-based biopharmaceutical company received $53.1M at the time of award and is expected to complete work by Aug. 10, 2021.
Client Solution Architects has appointed Ellen Barletto as chief growth officer, expanding her leadership responsibilities after nearly two decades with…
Brian Meyer, federal field chief technology officer at Axonius Federal, said cybersecurity asset management could help government agencies make dozens…
“Technology transformation company Red River has acquired Invictus International Consulting to expand its cybersecurity and enterprise modernization capabilities to support…
Synergy ECP, a software engineering, cybersecurity and systems engineering services provider, has acquired NetServices, a company offering secure, mission-focused technology services. The…
